** Medical equipment maker Thermo Fisher's shares TMO.N rise 2.2% to $444.39 premarket
** TMO posts Q1 adj. profit of $5.15 per share, beating analysts' estimates of $5.10 per share, according to data compiled by LSEG
** Company reports Q1 revenue of $10.36 billion vs estimates of $10.23 billion
** Sales at the company's laboratory products segment, which makes up more than half of its total sales, came in at $5.64 billion vs estimate of $5.65 billion
** As of last close, TMO has fallen 16.4% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。